Use access key #2 to skip to page content.

February 2008

Recs

1

Closing MNTA (Momenta) outperform

February 28, 2008 – Comments (0) | RELATED TICKERS: MNTA

Hopefully I haven't ended this outperform too soon. I still think Momenta is undervalued and the FDA immunogenicity concern is ridiculous. However, I'm not real happy with the pace of the company's response and from their recent conference call it seems like they haven't made any progress towards clarity with the FDA. I was hoping this was a concern that could be cleared up quickly, but the company has yet to establish if further clinical trials will be required. Furthermore, the share price seems to have plateaued after the initial recovery from the oversell. I'll be back if the share price drifts downward again in the absence of positive catalysts.  [more]

Recs

2

Closing EXAS (Exact Sciences) underperform

February 25, 2008 – Comments (0) | RELATED TICKERS: EXAS

I've resisted temptation to get out of this underperform earlier, and I've been rewarded with a 60% price drop. Right now, I really think I've got more to lose than to gain by holding the pick (only 30 more points to gain even if the price goes to 0). I'm tired of being nervous about the stock popping on short-term excitement over inclusion of DNA testing in some set of guidelines, even though I think long-term the company will fail. If there is another spike, I'll probably be there to short it again.  [more]

Featured Broker Partners


Advertisement